| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.4 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.41 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |